Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

por Ejegod, Ditte Møller, Rebolj, Matejka, Bonde, Jesper
Publicado 2015

Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening

por Ejegod, Ditte Møller, Pedersen, Helle, Alzua, Garazi Peña, Pedersen, Camilla, Bonde, Jesper
Publicado 2018

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening

por Rebolj, Matejka, Preisler, Sarah, Ejegod, Ditte Møller, Rygaard, Carsten, Lynge, Elsebeth, Bonde, Jesper
Publicado 2014

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system

por Bonde, Jesper, Rebolj, Matejka, Ejegod, Ditte Møller, Preisler, Sarah, Lynge, Elsebeth, Rygaard, Carsten
Publicado 2014

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study

por Preisler, Sarah, Rebolj, Matejka, Ejegod, Ditte Møller, Lynge, Elsebeth, Rygaard, Carsten, Bonde, Jesper
Publicado 2016

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework

por Bonde, Jesper Hansen, Pedersen, Helle, Quint, Wim, Xu, Lan, Arbyn, Marc, Ejegod, Ditte Møller
Publicado 2020

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay

por Preisler, Sarah, Rebolj, Matejka, Untermann, Anette, Ejegod, Ditte Møller, Lynge, Elsebeth, Rygaard, Carsten, Bonde, Jesper
Publicado 2013

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples

por Ejegod, Ditte Møller, Junge, Jette, Franzmann, Maria, Kirschner, Benny, Bottari, Fabio, Sideri, Mario, Sandri, Maria-Teresa, Bonde, Jesper
Publicado 2016

Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Pr...

por Ejegod, Ditte Møller, Pedersen, Helle, Pedersen, Birgitte Tønnes, Jonassen, Christine Monceyron, Lie, Agnes Kathrine, Hulleberg, Laila Solhaug, Arbyn, Marc, Bonde, Jesper
Publicado 2021

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework

por Bhatia, Ramya, Alcaniz Boada, Elia, Bonde, Jesper Hansen, Quint, Wim G V, Xu, Lan, Ejegod, Ditte Moller, Cuschieri, Kate, Arbyn, Marc
Publicado 2023

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus te...

por Ejegod, Ditte Møller, Lagheden, Camilla, Bhatia, Ramya, Pedersen, Helle, Boada, Elia Alcañiz, Sundström, Karin, Cortés, Javier, Josë, F. Xavier Bosch, Cuschieri, Kate, Dillner, Joakim, Bonde, Jesper
Publicado 2020